1. Home
  2. KOPN vs DBVT Comparison

KOPN vs DBVT Comparison

Compare KOPN & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOPN
  • DBVT
  • Stock Information
  • Founded
  • KOPN 1984
  • DBVT 2002
  • Country
  • KOPN United States
  • DBVT France
  • Employees
  • KOPN N/A
  • DBVT N/A
  • Industry
  • KOPN Semiconductors
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KOPN Technology
  • DBVT Health Care
  • Exchange
  • KOPN Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • KOPN 95.8M
  • DBVT 102.0M
  • IPO Year
  • KOPN 1992
  • DBVT N/A
  • Fundamental
  • Price
  • KOPN $0.91
  • DBVT $7.98
  • Analyst Decision
  • KOPN Strong Buy
  • DBVT Strong Buy
  • Analyst Count
  • KOPN 4
  • DBVT 2
  • Target Price
  • KOPN $2.63
  • DBVT $22.50
  • AVG Volume (30 Days)
  • KOPN 3.1M
  • DBVT 1.2M
  • Earning Date
  • KOPN 04-17-2025
  • DBVT 05-06-2025
  • Dividend Yield
  • KOPN N/A
  • DBVT N/A
  • EPS Growth
  • KOPN N/A
  • DBVT N/A
  • EPS
  • KOPN N/A
  • DBVT N/A
  • Revenue
  • KOPN $50,335,167.00
  • DBVT $4,151,000.00
  • Revenue This Year
  • KOPN $10.45
  • DBVT $1,679.52
  • Revenue Next Year
  • KOPN $22.49
  • DBVT $535.67
  • P/E Ratio
  • KOPN N/A
  • DBVT N/A
  • Revenue Growth
  • KOPN 24.61
  • DBVT N/A
  • 52 Week Low
  • KOPN $0.56
  • DBVT $0.44
  • 52 Week High
  • KOPN $2.17
  • DBVT $8.50
  • Technical
  • Relative Strength Index (RSI)
  • KOPN 41.68
  • DBVT 64.55
  • Support Level
  • KOPN $0.81
  • DBVT $7.00
  • Resistance Level
  • KOPN $0.94
  • DBVT $7.80
  • Average True Range (ATR)
  • KOPN 0.11
  • DBVT 0.96
  • MACD
  • KOPN 0.01
  • DBVT 0.07
  • Stochastic Oscillator
  • KOPN 71.43
  • DBVT 81.09

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: